Arbutus Biopharma Corp Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arbutus Biopharma Corp quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Arbutus Biopharma Corp Return On Equity for the quarter ending June 30, 2024 was -66.7 %, a 28.2% decline year-over-year.
  • Arbutus Biopharma Corp annual Return On Equity for 2023 was -57.8 %, a 25.2% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Equity for 2022 was -46.2 %, a 22.1% increase from 2021.
  • Arbutus Biopharma Corp annual Return On Equity for 2021 was -59.3 %, a 21.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -57.8 -11.6 -25.2% Jan 1, 2023 Dec 31, 2023
2022 -46.2 +13.1 +22.1% Jan 1, 2022 Dec 31, 2022
2021 -59.3 +16.2 +21.4% Jan 1, 2021 Dec 31, 2021
2020 -75.4 +47.1 +38.4% Jan 1, 2020 Dec 31, 2020
2019 -122 -96.7 -375% Jan 1, 2019 Dec 31, 2019
2018 -25.8 +21.5 +45.5% Jan 1, 2018 Dec 31, 2018
2017 -47.2 +49.5 +51.1% Jan 1, 2017 Dec 31, 2017
2016 -96.7 -85.7 -780% Jan 1, 2016 Dec 31, 2016
2015 -11 +28.4 +72.1% Jan 1, 2015 Dec 31, 2015
2014 -39.4 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.